Lipopolysaccharides-stimulated macrophage products enhance Withaferin A-induced apoptosis via activation of caspases and inhibition of NF-κB pathway in human cancer cells

Molecular Immunology

Volumn 81, Issue , 2017, Pages 92-101

  Piao, Liang ^a   Canguo, Zhao ^a   Wenjie, Lu ^a   Xiaoli, Cheng ^b   Wenli, Shi ^c   Li, Lu ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b HUBEI UNIVERSITY OF MEDICINE   (China)

^c GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

Author keywords

Apoptosis; Macrophage; NF B pathway; Withaferin A

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE; CASPASE 3; CASPASE 8; CASPASE 9; CELL EXTRACT; INHIBITOR OF APOPTOSIS PROTEIN 1; INHIBITOR OF APOPTOSIS PROTEIN 2; LIPOPOLYSACCHARIDE STIMULATED MACROPHAGE PRODUCT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; WITHAFERIN A; X LINKED INHIBITOR OF APOPTOSIS; CONDITIONED MEDIUM; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; WITHANOLIDE;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME METABOLISM; FEMALE; HUMAN; HUMAN CELL; MDA-MB-231 CELL LINE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BAGG ALBINO MOUSE; CELL PROLIFERATION; CONDITIONED MEDIUM; DRUG EFFECTS; FLOW CYTOMETRY; GENE SILENCING; IMMUNOLOGY; MACROPHAGE; METABOLISM; NEOPLASM; PHARMACOLOGY; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR MICROENVIRONMENT; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CASPASES; CELL LINE, TUMOR; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; ENZYME ACTIVATION; FEMALE; FLOW CYTOMETRY; GENE KNOCKDOWN TECHNIQUES; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED BALB C; NEOPLASMS; NF-KAPPA B; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; WITHANOLIDES;

EID: 85010223582     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2016.10.010     Document Type: Article

References (45)

1. Agarwal, R., Diwanay, S., Patki, P., Patwardhan, B., Studies on immunomodulatory activity of Withania somnifera (Ashwagandha) extracts in experimental immune inflammation. J. Ethnopharmacol. 67:1 (1999), 27–35.
2. Ahmad, M., Saleem, S., Ahmad, A.S., Ansari, M.A., Yousuf, S., Hoda, M.N., Islam, F., Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats. Hum. Exp. Toxicol. 24:3 (2005), 137–147.
3. Belgiovine, C., D'Incalci, M., Allavena, P., Frapolli, R., Tumor-associated macrophages and anti-tumor therapies: complex links. Cell. Mol. Life Sci. 73:13 (2016), 2411–2424.
4. Biswas, S.K., Mantovani, A., Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 11:10 (2010), 889–896.
5. Chanmee, T., Ontong, P., Konno, K., Itano, N., Tumor-associated macrophages as major players in the tumor microenvironment. Cancers 6:3 (2014), 1670–1690.
6. Clear, A.J., Lee, A.M., Calaminici, M., Ramsay, A.G., Morris, K.J., Hallam, S., Kelly, G., Macdougall, F., Lister, T.A., Gribben, J.G., Increased angiogenic sprouting in poor prognosis FL is associated with elevated numbers of CD163+ macrophages within the immediate sprouting microenvironment. Blood 115:24 (2010), 5053–5056.
7. De Palma, M., Lewis, C.E., Macrophage regulation of tumor responses to anticancer therapies. Cancer Cell 23:3 (2013), 277–286.
8. Deveraux, Q.L., Reed, J.C., IAP family proteins–suppressors of apoptosis. Genes Dev. 13:3 (1999), 239–252.
9. Fisher, D.T., Appenheimer, M.M., Evans, S.S., The two faces of IL-6 in the tumor microenvironment. Semin. Immunol. 26:1 (2014), 38–47.
10. Gordon, S., Martinez, F.O., Alternative activation of macrophages: mechanism and functions. Immunity 32:5 (2010), 593–604.
11. Gu, L., Zhu, N., Zhang, H., Durden, D.L., Feng, Y., Zhou, M., Regulation of XIAP translation and induction by MDM2 following irradiation. Cancer Cell 15:5 (2009), 363–375.
12. Gupta, S.K., Mohanty, I., Talwar, K.K., Dinda, A., Joshi, S., Bansal, P., Saxena, A., Arya, D.S., Cardioprotection from ischemia and reperfusion injury by Withania somnifera: a hemodynamic, biochemical and histopathological assessment. Mol. Cell. Biochem. 260:1–2 (2004), 39–47.
13. Holtermann, O.A., Klein, E., Casale, G.P., Selective cytotoxicity of peritoneal leucocytes for neoplastic cells. Cell. Immunol. 9:3 (1973), 339–352.
14. Hussain, A.R., Ahmed, M., Al-Jomah, N.A., Khan, A.S., Manogaran, P., Sultana, M., Abubaker, J., Platanias, L.C., Al-Kuraya, K.S., Uddin, S., Curcumin suppresses constitutive activation of nuclear factor-kappa B and requires functional Bax to induce apoptosis in Burkitt's lymphoma cell lines. Mol. Cancer Ther. 7:10 (2008), 3318–3329.
15. Jackson, S.S., Oberley, C., Hooper, C.P., Grindle, K., Wuerzberger-Davis, S., Wolff, J., McCool, K., Rui, L., Miyamoto, S., Withaferin A disrupts ubiquitin-based NEMO reorganization induced by canonical NF-kappaB signaling. Exp. Cell Res. 331:1 (2015), 58–72.
16. Jensen, J.L., Rakhmilevich, A., Heninger, E., Broman, A.T., Hope, C., Phan, F., Miyamoto, S., Maroulakou, I., Callander, N., Hematti, P., Tumoricidal effects of macrophage-activating immunotherapy in a murine model of relapsed/refractory multiple myeloma. Cancer Immunol. Res. 3:8 (2015), 881–890.
17. Karin, M., Cao, Y., Greten, F.R., Li, Z.W., NF-kappaB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2:4 (2002), 301–310.
18. Kumar, A., Sherlin, H.J., Ramani, P., Natesan, A., Premkumar, P., Expression of CD 68, CD 45 and human leukocyte antigen-DR in central and peripheral giant cell granuloma, giant cell tumor of long bones, and tuberculous granuloma: an immunohistochemical study. Indian J. Dent. Res. 26:3 (2015), 295–303.
19. LaCasse, E.C., Baird, S., Korneluk, R.G., MacKenzie, A.E., The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 17:25 (1998), 3247–3259.
20. Lee, W., Kim, T.H., Ku, S.K., Min, K.J., Lee, H.S., Kwon, T.K., Bae, J.S., Barrier protective effects of withaferin A in HMGB1-induced inflammatory responses in both cellular and animal models. Toxicol. Appl. Pharmacol. 262:1 (2012), 91–98.
21. Lewis, C.E., Harney, A.S., Pollard, J.W., The multifaceted role of perivascular macrophages in tumors. Cancer Cell 30:1 (2016), 18–25.
22. Li, X., Zhu, F., Jiang, J., Sun, C., Wang, X., Shen, M., Tian, R., Shi, C., Xu, M., Peng, F., Synergistic antitumor activity of withaferin A combined with oxaliplatin triggers reactive oxygen species-mediated inactivation of the PI3 K/AKT pathway in human pancreatic cancer cells. Cancer Lett. 357:1 (2015), 219–230.
23. Lin, W.W., Karin, M., A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest. 117:5 (2007), 1175–1183.
24. Lu, L., Kanwar, J., Schmitt, S., Cui, Q.C., Zhang, C., Zhao, C., Dou, Q.P., Inhibition of tumor cellular proteasome activity by triptolide extracted from the Chinese medicinal plant ‘thunder god vine'. Anticancer Res. 31:1 (2011), 1–10.
25. Lu, L., Shi, W., Deshmukh, R.R., Long, J., Cheng, X., Ji, W., Zeng, G., Chen, X., Zhang, Y., Dou, Q.P., Tumor necrosis factor-alpha sensitizes breast cancer cells to natural products with proteasome-inhibitory activity leading to apoptosis. PLoS One, 9(11), 2014, e113783.
26. Luo, Y., Knudson, M.J., Mycobacterium bovis bacillus Calmette-Guerin-induced macrophage cytotoxicity against bladder cancer cells. Clin. Dev. Immunol., 2010, 2010, 357591.
27. Mandal, C., Dutta, A., Mallick, A., Chandra, S., Misra, L., Sangwan, R.S., Mandal, C., Withaferin A induces apoptosis by activating p38 mitogen-activated protein kinase signaling cascade in leukemic cells of lymphoid and myeloid origin through mitochondrial death cascade. Apoptosis: Int. J. Program. Cell Death 13:12 (2008), 1450–1464.
28. Mantovani, A., Allavena, P., The interaction of anticancer therapies with tumor-associated macrophages. J. Exp. Med. 212:4 (2015), 435–445.
29. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A., Locati, M., The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25:12 (2004), 677–686.
30. Mantovani, A., Allavena, P., Sica, A., Balkwill, F., Cancer-related inflammation. Nature 454:7203 (2008), 436–444.
31. Matthews, N., Watkins, J.F., Tumour-necrosis factor from the rabbit I. Mode of action, specificity and physicochemical properties. Br. J. Cancer 38:2 (1978), 302–309.
32. Mohan, R., Hammers, H.J., Bargagna-Mohan, P., Zhan, X.H., Herbstritt, C.J., Ruiz, A., Zhang, L., Hanson, A.D., Conner, B.P., Rougas, J., Withaferin A is a potent inhibitor of angiogenesis. Angiogenesis 7:2 (2004), 115–122.
33. Mosser, D.M., Edwards, J.P., Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8:12 (2008), 958–969.
34. Murray, P.J., Wynn, T.A., Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11:11 (2011), 723–737.
35. Pahl, J.H., Kwappenberg, K.M., Varypataki, E.M., Santos, S.J., Kuijjer, M.L., Mohamed, S., Wijnen, J.T., van Tol, M.J., Cleton-Jansen, A.M., Egeler, R.M., et al. Macrophages inhibit human osteosarcoma cell growth after activation with the bacterial cell wall derivative liposomal muramyl tripeptide in combination with interferon-gamma. J. Exp. Clin.Cancer Res., 33, 2014, 27.
36. Ricardo, S.D., van Goor, H., Eddy, A.A., Macrophage diversity in renal injury and repair. J. Clin. Invest. 118:11 (2008), 3522–3530.
37. Riedl, S.J., Renatus, M., Schwarzenbacher, R., Zhou, Q., Sun, C., Fesik, S.W., Liddington, R.C., Salvesen, G.S., Structural basis for the inhibition of caspase-3 by XIAP. Cell 104:5 (2001), 791–800.
38. Schafer, Z.T., Brugge, J.S., IL-6 involvement in epithelial cancers. J. Clin. Invest. 117:12 (2007), 3660–3663.
39. Shiozaki, E.N., Chai, J., Rigotti, D.J., Riedl, S.J., Li, P., Srinivasula, S.M., Alnemri, E.S., Fairman, R., Shi, Y., Mechanism of XIAP-mediated inhibition of caspase-9. Mol. Cell 11:2 (2003), 519–527.
40. SoRelle, J.A., Itoh, T., Peng, H., Kanak, M.A., Sugimoto, K., Matsumoto, S., Levy, M.F., Lawrence, M.C., Naziruddin, B., Withaferin A inhibits pro-inflammatory cytokine-induced damage to islets in culture and following transplantation. Diabetologia 56:4 (2013), 814–824.
41. Tan, H.Y., Wang, N., Li, S., Hong, M., Wang, X., Feng, Y., The reactive oxygen species in macrophage polarization: reflecting its dual role in progression and treatment of human diseases. Oxid. Med. Cell. Longevity, 2016, 2016, 2795090.
42. Vanden Berghe, W., Sabbe, L., Kaileh, M., Haegeman, G., Heyninck, K., Molecular insight in the multifunctional activities of Withaferin A. Biochem. Pharmacol. 84:10 (2012), 1282–1291.
43. Xiao, Y., Bi, C., Fan, Y., Cui, C., Zhang, X., Dou, Q.P., L-Glutamine Schiff base copper complex as a proteasome inhibitor and an apoptosis inducer in human cancer cells. Int. J. Oncol. 33:5 (2008), 1073–1079.
44. Yang, H., Shi, G., Dou, Q.P., The tumor proteasome is a primary target for the natural anticancer compound Withaferin A isolated from Indian winter cherry. Mol. Pharmacol. 71:2 (2007), 426–437.
45. Zhang, X., Goncalves, R., Mosser, D.M., The isolation and characterization of murine macrophages. Curr. Adv. Immunol., 11, 2008 edited by John E Coligan [et al], Chapter 14:Unit 14.